You are here

  • Home
  • Archive
  • Volume 52, Issue 9
  • Contribution of the low-frequency, loss-of-function p.R270H mutation in FFAR4 (GPR120) to increased fasting plasma glucose levels

Article info

Article menu
Download PDFPDF
Complex traits
Short report
Contribution of the low-frequency, loss-of-function p.R270H mutation in FFAR4 (GPR120) to increased fasting plasma glucose levels

Authors

  • Amélie Bonnefond CNRS-UMR8199, Lille Pasteur Institute, Lille, France Lille University, Lille, France European Genomic Institute for Diabetes (EGID), Lille, France PubMed articlesGoogle scholar articles
  • Amel Lamri Inserm U-1138, Centre de Recherche des Cordeliers, Paris, France Paris-Diderot University, Sorbonne Paris-Cité, Paris, France Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada PubMed articlesGoogle scholar articles
  • Audrey Leloire CNRS-UMR8199, Lille Pasteur Institute, Lille, France Lille University, Lille, France European Genomic Institute for Diabetes (EGID), Lille, France PubMed articlesGoogle scholar articles
  • Emmanuel Vaillant CNRS-UMR8199, Lille Pasteur Institute, Lille, France Lille University, Lille, France European Genomic Institute for Diabetes (EGID), Lille, France PubMed articlesGoogle scholar articles
  • Ronan Roussel Inserm U-1138, Centre de Recherche des Cordeliers, Paris, France Paris-Diderot University, Sorbonne Paris-Cité, Paris, France Department of Endocrinology-Diabetology and Nutrition, DHU-FIRE, Bichat Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France PubMed articlesGoogle scholar articles
  • Claire Lévy-Marchal Inserm CIE 05—Department of Clinical Epidemiology, Robert Debré Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Jacques Weill Pediatric Endocrine Unit, Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • Pilar Galan Nutritional Epidemiology Research Group, Sorbonne-Paris-Cité, UMR University of Paris 13/Inserm U-557/INRA U-1125/CNAM, Bobigny, France PubMed articlesGoogle scholar articles
  • Serge Hercberg Nutritional Epidemiology Research Group, Sorbonne-Paris-Cité, UMR University of Paris 13/Inserm U-557/INRA U-1125/CNAM, Bobigny, France PubMed articlesGoogle scholar articles
  • Stéphanie Ragot Inserm, CIC1402 and U-1082, Poitiers, France Department of Endocrinology-Diabetology, Centre for Clinical Investigation, CHU of Poitiers, Poitiers, France University of Poitiers, UFR Medicine Pharmacy, Poitiers, France PubMed articlesGoogle scholar articles
  • Samy Hadjadj Inserm, CIC1402 and U-1082, Poitiers, France Department of Endocrinology-Diabetology, Centre for Clinical Investigation, CHU of Poitiers, Poitiers, France University of Poitiers, UFR Medicine Pharmacy, Poitiers, France PubMed articlesGoogle scholar articles
  • Guillaume Charpentier Department of Diabetes and Endocrinology, Centre Hospitalier Sud-Francilien, Corbeil-Essonne, France PubMed articlesGoogle scholar articles
  • Beverley Balkau Inserm U-1018, CESP, Team 5 (EpReC, Renal and cardiovascular Epidemiology), UVSQ-UPS, Villejuif, France PubMed articlesGoogle scholar articles
  • Michel Marre Inserm U-1138, Centre de Recherche des Cordeliers, Paris, France Paris-Diderot University, Sorbonne Paris-Cité, Paris, France Department of Endocrinology-Diabetology and Nutrition, DHU-FIRE, Bichat Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France PubMed articlesGoogle scholar articles
  • Frédéric Fumeron Inserm U-1138, Centre de Recherche des Cordeliers, Paris, France Paris-Diderot University, Sorbonne Paris-Cité, Paris, France PubMed articlesGoogle scholar articles
  • Philippe Froguel CNRS-UMR8199, Lille Pasteur Institute, Lille, France Lille University, Lille, France European Genomic Institute for Diabetes (EGID), Lille, France Department of Genomics of Common Disease, School of Public Health, Imperial College London, Hammersmith Hospital, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Amélie Bonnefond or Prof Philippe Froguel, CNRS UMR8199, Lille Pasteur Institute, 1 rue du Prof Calmette, Lille Cedex 59019, France; amelie{at}good.ibl.fr or froguel{at}good.ibl.fr
View Full Text

Citation

Bonnefond A, Lamri A, Leloire A, et al
Contribution of the low-frequency, loss-of-function p.R270H mutation in FFAR4 (GPR120) to increased fasting plasma glucose levels
Journal of Medical Genetics 2015;52:595-598.

Publication history

  • Received February 7, 2015
  • Revised April 11, 2015
  • Accepted May 4, 2015
  • First published May 29, 2015.
Online issue publication 
January 20, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions